Identification and characterisation of the dose response of otelixizumab in new onset type 1 diabetes patients
Published in 2019 by
A. Napolitano,
A. van Maurik,
Derek Inman,
N. Wisniacki,
Pieter Gillard,
Robert Hilbrands,
Frans Gorus 
,
Chantal Mathieu,
Ursule Van De Velde,
Bart Keymeulen
,
Chantal Mathieu,
Ursule Van De Velde,
Bart Keymeulen
